FDA Issues Draft Guidance Regarding Controlled Correspondence from Generics Manufacturers
By EsqSocial Corporation 10/09/14
On August 26, 2014, the FDA issued draft guidance to address “controlled correspondence,” which is the correspondence that generic drug manufacturers submit to the FDA to request information and to clarify issues related to generic drug development,...
By: Mintz Levin - Consumer Product Matters